TORNTPHARM

Torrent Pharmaceuticals Limited

Branded-generics pharma in India and Brazil, scaled up by acquiring JB Chemicals

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

torrentpharma.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹4558.90
Market cap
1,73,406 Cr
Stock P/E
70.7
P/B
18.37
Dividend yield
0.7%
ROE (FY26)
12.3%
ROCE (FY26)
10.1%
Operating margin (FY26)
24.6%
Debt / equity (FY26)
1.76
OCF / EBITDA (FY26)
66.3%
OCF / EBITDA (3Y)
76.2%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Torrent Pharma (Torrent Pharmaceuticals) makes and sells branded generic medicines, mainly in India and Brazil, with generics sales in the US and Germany.

Company snapshot

3rdBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓Net margin of 15.3% — the business keeps a healthy share of every rupee it earns.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales2,660 Cr2,732 Cr2,745 Cr2,859 Cr2,889 Cr2,809 Cr2,959 Cr3,178 Cr3,302 Cr3,303 Cr4,197 Cr4,921 Cr
Operating expenses (approx.)1,835 Cr1,863 Cr1,862 Cr1,955 Cr1,950 Cr1,895 Cr1,995 Cr2,146 Cr2,219 Cr2,215 Cr2,841 Cr3,257 Cr
EBITDA825 Cr869 Cr883 Cr904 Cr939 Cr914 Cr964 Cr1,032 Cr1,083 Cr1,088 Cr1,356 Cr1,664 Cr
OPM %31.0%31.8%32.2%31.6%32.5%32.5%32.6%32.5%32.8%32.9%32.3%33.8%
Other income26 Cr-33 Cr31 Cr24 Cr-16 Cr33 Cr-18 Cr-37 Cr-27 Cr-13 Cr-17 Cr-12 Cr
Interest91 Cr80 Cr80 Cr75 Cr64 Cr57 Cr56 Cr56 Cr48 Cr45 Cr236 Cr305 Cr
Depreciation201 Cr213 Cr203 Cr197 Cr198 Cr199 Cr201 Cr201 Cr204 Cr206 Cr508 Cr593 Cr
Profit before tax559 Cr631 Cr631 Cr656 Cr661 Cr691 Cr665 Cr738 Cr791 Cr814 Cr529 Cr733 Cr
Tax %30.9%29.8%28.8%30.3%31.5%27.2%25.1%25.7%25.3%22.0%31.2%22.8%
Net profit386 Cr443 Cr449 Cr457 Cr453 Cr503 Cr498 Cr548 Cr591 Cr635 Cr364 Cr566 Cr
EPS (₹)₹11.39₹13.10₹13.27₹13.51₹13.37₹14.88₹14.71₹16.19₹17.45₹18.77₹11.51₹14.87

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5,857 Cr6,002 Cr7,673 Cr7,939 Cr8,005 Cr8,508 Cr9,620 Cr10,728 Cr11,516 Cr13,980 CrSign in free for the trailing twelve months
Operating expenses (approx.)4,480 Cr4,653 Cr5,689 Cr5,769 Cr5,520 Cr6,077 Cr6,778 Cr7,360 Cr7,795 Cr9,421 CrSign in free for the trailing twelve months
EBITDA1,377 Cr1,349 Cr1,984 Cr2,170 Cr2,485 Cr2,431 Cr2,842 Cr3,368 Cr3,721 Cr4,559 CrSign in free for the trailing twelve months
OPM %23.5%22.5%25.9%27.3%31.0%28.6%29.5%31.4%32.3%32.6%Sign in free for the trailing twelve months
Other income223 Cr299 Cr57 Cr122 Cr57 Cr197 Cr45 Cr58 Cr23 Cr-94 CrSign in free for the trailing twelve months
Interest206 Cr308 Cr504 Cr451 Cr358 Cr255 Cr333 Cr354 Cr252 Cr385 CrSign in free for the trailing twelve months
Depreciation307 Cr409 Cr618 Cr654 Cr658 Cr662 Cr707 Cr808 Cr795 Cr1,119 CrSign in free for the trailing twelve months
Profit before tax1,088 Cr931 Cr562 Cr1,187 Cr1,526 Cr1,226 Cr1,847 Cr2,352 Cr2,673 Cr2,872 CrSign in free for the trailing twelve months
Tax %14.2%27.2%22.4%13.6%18.0%36.6%32.6%29.6%28.5%25.6%Sign in free for the trailing twelve months
Net profit934 Cr678 Cr436 Cr1,025 Cr1,252 Cr777 Cr1,245 Cr1,656 Cr1,911 Cr2,138 CrSign in free for the trailing twelve months
EPS (₹)₹55.17₹40.07₹25.78₹60.55₹73.98₹45.93₹36.79₹48.94₹56.47₹63.92Sign in free for the trailing twelve months
Dividend payout %————27.0%87.1%69.3%61.3%56.7%60.3%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital85 Cr85 Cr85 Cr85 Cr85 Cr85 Cr169 Cr169 Cr169 Cr169 Cr
Reserves4,266 Cr4,538 Cr4,639 Cr4,739 Cr5,753 Cr5,868 Cr6,029 Cr6,687 Cr7,422 Cr8,220 Cr
Borrowings2,241 Cr5,737 Cr4,847 Cr4,395 Cr3,645 Cr4,018 Cr5,297 Cr3,938 Cr3,026 Cr14,798 Cr
Other liabilities3,111 Cr3,883 Cr4,550 Cr4,819 Cr4,592 Cr3,129 Cr3,517 Cr4,267 Cr4,373 Cr11,929 Cr
Total liabilities9,702 Cr14,243 Cr14,121 Cr14,038 Cr14,075 Cr13,100 Cr15,012 Cr15,061 Cr14,990 Cr44,312 Cr
Fixed assets (net)1,871 Cr2,417 Cr2,801 Cr2,953 Cr2,884 Cr2,703 Cr2,772 Cr3,297 Cr3,455 Cr4,909 Cr
CWIP463 Cr423 Cr479 Cr577 Cr745 Cr544 Cr688 Cr281 Cr367 Cr457 Cr
Investments804 Cr492 Cr353 Cr2 Cr181 Cr226 Cr199 Cr173 Cr156 Cr962 Cr
Loans & advances——4 Cr4 Cr3 Cr3 Cr2 Cr3 Cr5 Cr5 Cr
Inventories1,559 Cr1,966 Cr1,935 Cr2,148 Cr2,681 Cr2,462 Cr2,230 Cr2,279 Cr2,541 Cr3,138 Cr
Trade receivables951 Cr1,253 Cr1,436 Cr1,649 Cr1,523 Cr1,633 Cr1,944 Cr1,844 Cr1,867 Cr3,031 Cr
Cash & bank279 Cr241 Cr589 Cr662 Cr573 Cr398 Cr508 Cr835 Cr573 Cr1,117 Cr
Other assets3,775 Cr7,450 Cr6,524 Cr6,043 Cr5,485 Cr5,131 Cr6,669 Cr6,349 Cr6,026 Cr30,693 Cr
Total assets9,702 Cr14,243 Cr14,121 Cr14,038 Cr14,075 Cr13,100 Cr15,012 Cr15,061 Cr14,990 Cr44,312 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity1,009 Cr894 Cr1,798 Cr1,392 Cr2,011 Cr1,803 Cr2,368 Cr3,266 Cr2,585 Cr3,023 Cr
Cash from investing-787 Cr-4,707 Cr-241 Cr-152 Cr-449 Cr-198 Cr-2,356 Cr-168 Cr-540 Cr-12,713 Cr
Cash from financing-193 Cr3,417 Cr-1,314 Cr-1,549 Cr-1,656 Cr-1,781 Cr77 Cr-2,779 Cr-2,298 Cr10,151 Cr
Net cash flow29 Cr-395 Cr242 Cr-309 Cr-89 Cr-175 Cr110 Cr327 Cr-262 Cr544 Cr
Free cash flow (OCF − Capex)522 Cr103 Cr1,135 Cr985 Cr1,676 Cr1,600 Cr1,794 Cr2,833 Cr1,974 Cr2,346 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %19.6%12.0%11.1%17.8%19.9%14.9%19.0%25.1%27.6%10.1%
ROE %21.5%14.7%9.2%21.2%21.4%13.1%20.1%24.2%25.2%12.3%
Debtor days59766876697074635979
Inventory days481689546569687583548502609650
Days payable539718592550529396413460436488
Cash conversion cycle0472295227256209105232240
OCF / EBITDA %73.2%66.3%90.6%64.1%80.9%74.2%83.3%97.0%69.5%66.3%
OCF / EBITDA % (3 years)——78.6%74.2%78.3%73.5%79.7%86.1%82.8%76.2%
Debt / equity0.521.241.030.910.620.670.850.570.401.76
Current ratio1.781.010.980.911.131.170.981.031.191.13
Net debt / EBITDA1.42—2.151.721.241.491.690.920.663.00